Sanofi’s Cablivi cleared for rare bleeding disorder
admin 3rd September 2018 Uncategorised 0Patients with the rare clotting disorder acquired thrombotic thrombocytopenic purpura (aTTP) have gained a new treatment option in Europe with the approval of Sanofi’s Cablivi.
More: Sanofi’s Cablivi cleared for rare bleeding disorder
Source: News